436 related articles for article (PubMed ID: 32396491)
1. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
[TBL] [Abstract][Full Text] [Related]
2. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
[No Abstract] [Full Text] [Related]
3. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
Nabhan C; Choueiri TK; Mato AR
JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
[No Abstract] [Full Text] [Related]
4. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
[No Abstract] [Full Text] [Related]
5. Patients with cancer in the COVID-19 era: the clinical trial issue.
Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
[TBL] [Abstract][Full Text] [Related]
6. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
Tan AC; Ashley DM; Khasraw M
Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
[TBL] [Abstract][Full Text] [Related]
7. Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.
Dhawan N; Prommer E; Sinclair CT; Subbiah IM
Curr Treat Options Oncol; 2020 Oct; 21(12):99. PubMed ID: 33119833
[No Abstract] [Full Text] [Related]
8. Palliative Care for Patients With Cancer in the COVID-19 Era.
Mehta AK; Smith TJ
JAMA Oncol; 2020 Oct; 6(10):1527-1528. PubMed ID: 32379855
[No Abstract] [Full Text] [Related]
9. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
Moskowitz CS; Panageas KS
JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
[No Abstract] [Full Text] [Related]
10. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
[No Abstract] [Full Text] [Related]
11. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
Rubinstein SM; Steinharter JA; Warner J; Rini BI; Peters S; Choueiri TK
Cancer Cell; 2020 Jun; 37(6):738-741. PubMed ID: 32454025
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
13. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
Balogun OD; Bea VJ; Phillips E
JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
[No Abstract] [Full Text] [Related]
14. Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.
Hofman P; Puchois P; Brest P; Lahlou H; Simeon-Dubach D
Nat Med; 2020 Jun; 26(6):809-810. PubMed ID: 32382152
[No Abstract] [Full Text] [Related]
15. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
16. Considerations for the Management of Oncology Patients During the COVID-19 Pandemic.
Huang J; Rohatgi A; Schneider J; Braunstein M
Oncology (Williston Park); 2020 Oct; 34(10):432-441. PubMed ID: 33058111
[TBL] [Abstract][Full Text] [Related]
17. NCI's Work to Advance Cancer Research while Responding to the COVID-19 Pandemic.
Singer DS
Cancer Cell; 2020 Jun; 37(6):746-748. PubMed ID: 32425703
[TBL] [Abstract][Full Text] [Related]
18. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
[No Abstract] [Full Text] [Related]
19. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
Gharzai LA; Resnicow K; An LC; Jagsi R
JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
[TBL] [Abstract][Full Text] [Related]
20. The World of Clinical Trial Development Post COVID-19: Lessons Learned from a Global Pandemic.
Karzai F; Madan RA; Dahut WL
Clin Cancer Res; 2020 Aug; 26(16):4198-4200. PubMed ID: 32503806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
